GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Gross Margin %

Brooks Laboratories (BOM:533543) Gross Margin % : 28.23% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Brooks Laboratories's Gross Profit for the three months ended in Mar. 2024 was ₹50.0 Mil. Brooks Laboratories's Revenue for the three months ended in Mar. 2024 was ₹177.2 Mil. Therefore, Brooks Laboratories's Gross Margin % for the quarter that ended in Mar. 2024 was 28.23%.


The historical rank and industry rank for Brooks Laboratories's Gross Margin % or its related term are showing as below:

BOM:533543' s Gross Margin % Range Over the Past 10 Years
Min: 15.87   Med: 23.11   Max: 31.17
Current: 28.45


During the past 13 years, the highest Gross Margin % of Brooks Laboratories was 31.17%. The lowest was 15.87%. And the median was 23.11%.

BOM:533543's Gross Margin % is ranked worse than
80.51% of 985 companies
in the Drug Manufacturers industry
Industry Median: 47 vs BOM:533543: 28.45

Brooks Laboratories had a gross margin of 28.23% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Brooks Laboratories was 4.50% per year.


Brooks Laboratories Gross Margin % Historical Data

The historical data trend for Brooks Laboratories's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Gross Margin % Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.65 28.30 15.87 19.94 28.77

Brooks Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.84 35.38 28.19 28.92 28.23

Competitive Comparison of Brooks Laboratories's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's Gross Margin % falls into.



Brooks Laboratories Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Brooks Laboratories's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=228.7 / 794.861
=(Revenue - Cost of Goods Sold) / Revenue
=(794.861 - 566.19) / 794.861
=28.77 %

Brooks Laboratories's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=50 / 177.217
=(Revenue - Cost of Goods Sold) / Revenue
=(177.217 - 127.195) / 177.217
=28.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Brooks Laboratories  (BOM:533543) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Brooks Laboratories had a gross margin of 28.23% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Brooks Laboratories Gross Margin % Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories (BOM:533543) Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (BOM:533543) Headlines

No Headlines